Kolkata, India

Vineeta Sharma

This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Vineeta Sharma in Diagnosing Visceral Leishmaniasis

Introduction

Vineeta Sharma is a notable inventor based in Kolkata, India. She has made significant contributions to the field of medical diagnostics, particularly in the identification of visceral leishmaniasis. Her innovative approach has the potential to enhance the accuracy and speed of diagnosing this disease.

Latest Patents

Vineeta Sharma holds a patent for a method that focuses on diagnosing visceral leishmaniasis in patients. This invention relates to the identification of a new key marker, namely 9-O-Acetylated sialoglycoconjugate, using a known 9-O acetylsialic acid binding lectin, Achatinin-H. This method is particularly useful for the diagnosis of visceral leishmaniasis through a rapid and accurate haemagglutination assay. She has 1 patent to her name.

Career Highlights

Vineeta Sharma is associated with the Council of Scientific and Industrial Research, where she has been involved in groundbreaking research. Her work has contributed to advancements in medical diagnostics, showcasing her dedication to improving healthcare outcomes.

Collaborations

Some of her notable coworkers include Chitra Mandal and Mitali Chatterjee. Their collaborative efforts have furthered the research and development of innovative diagnostic methods.

Conclusion

Vineeta Sharma's contributions to the field of medical diagnostics, particularly through her patent for diagnosing visceral leishmaniasis, highlight her role as an influential inventor. Her work continues to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…